Streetbeat News

Products Services

LDOS

Leidos has secured a $51 million contract to enhance missile warning capabilities for the U.S. Space Systems Command. The contract involves providing Model Based Systems Engineering, software integration, and deployment to improve data processing and accuracy of missile warning systems.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 12:04 pm

OCEA

Ocean Biomedical's scientific co-founder, Jonathan Kurtis, has been issued a US patent for the PfGARP malaria antibody, which could have significant implications for malaria treatment.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 12:03 pm

POAI

Predictive Oncology has announced the results of a study demonstrating the long-term stability and viability of over 150,000 cryopreserved patient tumor samples at its biobank. This development could enhance the company's research capabilities and attract more partnerships.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 12:01 pm

JNVR

Janover Inc. (NASDAQ: JNVR) has launched Janover Pro, a subscription-based service providing access to a comprehensive dataset of commercial lenders. This service aims to democratize data access for smaller operators, offering tools used by major industry players. The platform is expected to evolve with AI integration.

Portfolio Pulse from Anusuya Lahiri

August 27, 2024 | 12:00 pm

AMD

INTC

IVW

NVDA

VGT

Nvidia's stock surge has significantly reduced employee churn, turning many employees into millionaires. The company's stock grants and AI-driven growth have been key factors. Meanwhile, Intel plans significant workforce reductions.

Portfolio Pulse from Anusuya Lahiri

August 27, 2024 | 12:00 pm

JNVR

Janover has announced that its Janover Pro platform provides extensive access to a network of multifamily, commercial property, and SBA lenders, including a significant portion of U.S. banks and top credit unions.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 12:00 pm

JNVR

Janover has launched Janover Pro, a subscription-based service providing access to commercial lender data. This new service aims to enhance the company's offerings and attract more users.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 12:00 pm

ADXN

Addex Therapeutics shares rose as the company, in collaboration with Indivior, selected clinical candidates from their GABAB positive allosteric modulator research. Addex is eligible for up to $330 million in milestone payments and royalties.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 11:53 am

ARAY

Accuray has received the CE Mark for its Accuray Helix, a CT-guided helical radiotherapy system. This system targets emerging markets with limited access to advanced cancer care.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 11:50 am

NVDA

NVDD

NVDU

Nvidia is set to release its Q2 2025 earnings, with analysts expecting strong results. However, opinions are mixed, leading to potential volatility. Direxion's NVDA-focused ETFs, NVDU and NVDD, offer opportunities for both bullish and bearish traders.

Portfolio Pulse from Joshenomoto@benzinga.com

August 27, 2024 | 11:48 am